Filed: 2/17/2026ACC: 0001193125-26-053151
📋 What this filing means
FCPM III SERVICES B.V. filed this quarterly 13F‑HR report disclosing 10 equity positions with a total reported market value of $762.89M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
10
Positions
$762.89M
Total AUM (reported)
43.80M
Total Shares
Allocation by class
ORDINARY SHARES$322.70M42.3%
COM$297.70M39.0%
COM NEW$109.41M14.3%
SPONSORED ADS$24.56M3.2%
W EXP 10/31/2028$8.52M1.1%
Portfolio Concentration
Top 3$516.53M67.7%
4–10$246.35M32.3%
Top 3 weight
67.7%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 43.80M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
43.80M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other10
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings10
Rows:
NEWAMSTERDAM PHARMA COMPANY
DFNDShares9.20M
TypeSH
Market value$322.70M
42.30%
Sole
0.00
Shared
9.20M
None
0.00
DYNE THERAPEUTICS INC
DFNDShares5.46M
TypeSH
Market value$106.85M
14.01%
Sole
0.00
Shared
5.46M
None
0.00
ENGENE HOLDINGS INC
DFNDShares9.63M
TypeSH
Market value$86.98M
11.40%
Sole
0.00
Shared
9.63M
None
0.00
RAPT THERAPEUTICS INC
DFNDShares1.83M
TypeSH
Market value$62.09M
8.14%
Sole
0.00
Shared
1.83M
None
0.00
MAPLIGHT THERAPEUTICS INC
DFNDShares3.23M
TypeSH
Market value$56.67M
7.43%
Sole
0.00
Shared
3.23M
None
0.00
VOR BIOPHARMA INC
DFNDShares3.62M
TypeSH
Market value$47.31M
6.20%
Sole
0.00
Shared
3.62M
None
0.00
REPLIMUNE GROUP INC
DFNDShares2.81M
TypeSH
Market value$27.30M
3.58%
Sole
0.00
Shared
2.81M
None
0.00
BICYCLE THERAPEUTICS PLC
DFNDShares3.47M
TypeSH
Market value$24.56M
3.22%
Sole
0.00
Shared
3.47M
None
0.00
CRESCENT BIOPHARMA INC.
DFNDShares1.68M
TypeSH
Market value$19.90M
2.61%
Sole
0.00
Shared
1.68M
None
0.00
ENGENE HOLDINGS INC
DFNDShares2.88M
TypeSH
Market value$8.52M
1.12%
Sole
0.00
Shared
2.88M
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
NEWAMSTERDAM PHARMA COMPANYDFND | ORDINARY SHARES | 9.20M | SH | $322.70M 42.30% | 0.00 | 9.20M | 0.00 |
DYNE THERAPEUTICS INCDFND | COM | 5.46M | SH | $106.85M 14.01% | 0.00 | 5.46M | 0.00 |
ENGENE HOLDINGS INCDFND | COM | 9.63M | SH | $86.98M 11.40% | 0.00 | 9.63M | 0.00 |
RAPT THERAPEUTICS INCDFND | COM NEW | 1.83M | SH | $62.09M 8.14% | 0.00 | 1.83M | 0.00 |
MAPLIGHT THERAPEUTICS INCDFND | COM | 3.23M | SH | $56.67M 7.43% | 0.00 | 3.23M | 0.00 |
VOR BIOPHARMA INCDFND | COM NEW | 3.62M | SH | $47.31M 6.20% | 0.00 | 3.62M | 0.00 |
REPLIMUNE GROUP INCDFND | COM | 2.81M | SH | $27.30M 3.58% | 0.00 | 2.81M | 0.00 |
BICYCLE THERAPEUTICS PLCDFND | SPONSORED ADS | 3.47M | SH | $24.56M 3.22% | 0.00 | 3.47M | 0.00 |
CRESCENT BIOPHARMA INC.DFND | COM | 1.68M | SH | $19.90M 2.61% | 0.00 | 1.68M | 0.00 |
ENGENE HOLDINGS INCDFND | W EXP 10/31/2028 | 2.88M | SH | $8.52M 1.12% | 0.00 | 2.88M | 0.00 |